Publications by authors named "Harry W Findley"

Claim this Profile
A
A switching mechanism in doxorubicin bioactivation can be exploited to control doxorubicin toxicity.
Nnenna A Finn, Harry W Findley, Melissa L Kemp

PLoS Comput Biol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor intervention.
Susan K Peirce, Harry W Findley, Chengyu Prince, Anindya Dasgupta, Todd Cooper

Cancer Chemother Pharmacol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and functional role of inhibitor-of-apoptosis protein livin (BIRC7) in neuroblastoma.
Anindya Dasgupta, Carlos S Alvarado, Zhiheng Xu, Harry W Findley

Biochem Biophys Res Commun· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial.
Alan S Wayne, Robert J Kreitman, Harry W Findley, Glen Lew, Cynthia Delbrook

Clin Cancer Res· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High level MycN expression in non-MYCN amplified neuroblastoma is induced by the combination treatment nutlin-3 and doxorubicin and enhances chemosensitivity.
Susan K Peirce, Harry W Findley

Oncol Rep· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells.
Hal E Crosswell, Anindya Dasgupta, Carlos S Alvarado, Tanya Watt, James G Christensen, Harry W Findley

BMC Cancer· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MycN is a transcriptional regulator of livin in neuroblastoma.
Anindya Dasgupta, Susan K Peirce, Harry W Findley

Oncol Rep· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation.
Elin Hallan Naderi, Harry W Findley, Ellen Ruud, Heidi Kiil Blomhoff, Soheil Naderi

Blood· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MDM2 antagonist nutlin-3 sensitizes p53-null neuroblastoma cells to doxorubicin via E2F1 and TAp73.
Susan K Peirce, Harry W Findley

Int J Oncol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
Lubing Gu, Kuang-Yueh Chiang, Ningxi Zhu, Harry W Findley, Muxiang Zhou

Exp Hematol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KLF5 Interacts with p53 in regulating survivin expression in acute lymphoblastic leukemia.
Ningxi Zhu, Lubing Gu, Harry W Findley, Ceshi Chen, Jin-Tang Dong

J Biol Chem· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome.
Dae-Kwang Kim, Carlos S Alvarado, Carlos R Abramowsky, Lubing Gu, Muxiang Zhou, Harry W Findley

Pediatr Dev Pathol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional repression of the eukaryotic initiation factor 4E gene by wild type p53.
Ningxi Zhu, Lubing Gu, Harry W Findley, Muxiang Zhou

Biochem Biophys Res Commun· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of the IKKalpha promoter: positive and negative regulation by ETS-1 and p53, respectively.
Lubing Gu, Ningxi Zhu, Harry W Findley, William G Woods, Muxiang Zhou

J Biol Chem· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy.
Ningxi Zhu, Lubing Gu, Harry W Findley, Fengzhi Li, Muxiang Zhou

Oncogene· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfection of a dominant-negative mutant NF-kB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IkBm and p53.
Muxiang Zhou, Lubing Gu, Ningxi Zhu, William G Woods, Harry W Findley

Oncogene· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
Muxiang Zhou, Lubing Gu, Harry W Findley, Rong Jiang, William G Woods

Cancer Res· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of Vh gene replacement to the primary B cell repertoire.
Zhixin Zhang, Michael Zemlin, Yui-Hsi Wang, Delicia Munfus, Leslie E Huye, Harry W Findley

Immunity· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular mechanism of serial VH gene replacement.
Zhixin Zhang, Yui-Hsi Wang, Michael Zemlin, Harry W Findley, S Louis Bridges

Ann N Y Acad Sci· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
V(D)J recombinatorial repertoire diversification during intraclonal pro-B to B-cell differentiation.
Yui-Hsi Wang, Zhixin Zhang, Peter D Burrows, Hiromi Kubagawa, S Louis Bridges, Harry W Findley

Blood· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells.
Muxiang Zhou, Lubing Gu, Fengzhi Li, Yerun Zhu, William G Woods, Harry W Findley

J Pharmacol Exp Ther· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variable Expression and Hypermethylation of p16 Gene in Patients with T-ALL and Cell Lines.
Yusuf Özkul, Ingrid Jurickova, Harry W W Findley

Turk J Haematol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of DR5 and Fas expression levels relative to the chemosensitivity of acute lymphoblastic leukemia cell lines.
Viengthong Lam, Harry W Findley, John C Reed, Melvin H Freedman, Gerald J Goldenberg

Leuk Res· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDM2 induces NF-kappaB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia.
Lubing Gu, Harry W Findley, Muxiang Zhou

Blood· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis